Experience of Clinical Pharmacists Participating in the Therapy for one Neurilemmoma Cancer Patient with Malignant Neuropathic Pain
- VernacularTitle:临床药师参与1例骶骨恶性神经鞘瘤患者神经病理性疼痛的治疗体会
- Author:
Yujiao GUO
1
;
Ling MENG
;
Can LUO
;
Dewang WANG
Author Information
1. 南京医科大学第一附属医院 南京210029
- Keywords:
Clinical pharmacist;
Cancer patients;
Malignant neuropathic pain
- From:
China Pharmacist
2017;20(10):1815-1816,1819
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To improve the safety, rationality and efficacy of medication for cancer patients accompanied with malignant neuropathic pain by the participation of clinical pharmacists in the therapy. Methods:Clinical pharmacists participated in the therapy for one neurilemmoma cancer patient with malignant neuropathic pain, and provided a rational and individualized therapeutic regimen according to the drug experience of clinical pharmacists as well as the relevant medical guides and literatures. Results: According to the nature and degree of pain, clinical pharmacists adjusted the type and dosage of opioids and non opioid drugs. The pain was well controlled with pain score at 1-2 points. Besides, the adverse effects were alleviated to ensure the sustained drug treatment. Conclu-sion:The participation of clinical pharmacists in therapeutic practice can improve the normalization of pharmacotherapy for neurilem-moma cancer patients with malignant neuropathic pain, which also can provide ideas and methods for treating the similar patients.
